TipRanks
Advertisement
Advertisement

AU:NTI Stock Latest News

Neurotech Starts Pivotal Phase 3 Trial of NTI164 for Autism
Company AnnouncementsNeurotech Starts Pivotal Phase 3 Trial of NTI164 for Autism
7d ago
NTI
NTI164 Rett Trial Moves Toward Phase II/III: What Investors Should Watch
PremiumCompany Announcements
NTI164 Rett Trial Moves Toward Phase II/III: What Investors Should Watch
18d ago
NTI
Neurotech International Adds Major Shareholder Andrew Chapman to Board
PremiumCompany Announcements
Neurotech International Adds Major Shareholder Andrew Chapman to Board
19d ago
NTI
Neurotech International Options Lapse Simplifies Capital Structure
PremiumCompany Announcements
Neurotech International Options Lapse Simplifies Capital Structure
19d ago
NTI
Neurotech reshapes board as it advances paediatric cannabinoid trials
PremiumCompany Announcements
Neurotech reshapes board as it advances paediatric cannabinoid trials
20d ago
NTI
Neurotech Discloses Final Director Interest as Anthony Filippis Steps Down
PremiumCompany AnnouncementsNeurotech Discloses Final Director Interest as Anthony Filippis Steps Down
20d ago
NTI
Neurotech Narrows Loss as R&D Grants Drive Revenue Surge
Premium
Company Announcements
Neurotech Narrows Loss as R&D Grants Drive Revenue Surge
1M ago
NTI
Neurotech Elevates Mark Davies to Executive Chairman as Phase III Cannabinoid Program Advances
Premium
Company Announcements
Neurotech Elevates Mark Davies to Executive Chairman as Phase III Cannabinoid Program Advances
1M ago
NTI
Neurotech Confirms Compliance as New Shares Enter Secondary Trading
PremiumCompany Announcements
Neurotech Confirms Compliance as New Shares Enter Secondary Trading
2M ago
NTI
Neurotech International Seeks ASX Quotation for 293 Million New Shares
PremiumCompany Announcements
Neurotech International Seeks ASX Quotation for 293 Million New Shares
2M ago
NTI
Neurotech raises $4.5m to fund pivotal ASD Phase III trial
PremiumCompany Announcements
Neurotech raises $4.5m to fund pivotal ASD Phase III trial
2M ago
NTI
Neurotech secures FDA IND nod and U.S. patent wins as autism drug program advances
PremiumCompany Announcements
Neurotech secures FDA IND nod and U.S. patent wins as autism drug program advances
2M ago
NTI
Neurotech Autism Trial Data Secures Publication in Leading Neurotherapeutics Journal
PremiumCompany AnnouncementsNeurotech Autism Trial Data Secures Publication in Leading Neurotherapeutics Journal
2M ago
NTI
Neurotech taps $3.15m R&D tax loan to fund Phase III ASD trials
Premium
Company Announcements
Neurotech taps $3.15m R&D tax loan to fund Phase III ASD trials
2M ago
NTI
Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy
Premium
Company Announcements
Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy
3M ago
NTI
Neurotech International Issues 19.5 Million New Unlisted Options
PremiumCompany Announcements
Neurotech International Issues 19.5 Million New Unlisted Options
3M ago
NTI
Neurotech Wins Key U.S. Patent Allowances for NTI164 Autism Therapy
PremiumCompany Announcements
Neurotech Wins Key U.S. Patent Allowances for NTI164 Autism Therapy
3M ago
NTI
Neurotech International Options Lapse, Reducing Potential Share Dilution
PremiumCompany Announcements
Neurotech International Options Lapse, Reducing Potential Share Dilution
3M ago
NTI
Neurotech Director Options Expire Without Exercise
PremiumCompany Announcements
Neurotech Director Options Expire Without Exercise
5M ago
NTI
Neurotech Options Lapse, Trimming Potential Future Dilution
PremiumCompany AnnouncementsNeurotech Options Lapse, Trimming Potential Future Dilution
5M ago
NTI
Maybank Securities Exits Substantial Holder Position in Neurotech International
Premium
Company Announcements
Maybank Securities Exits Substantial Holder Position in Neurotech International
5M ago
NTI
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
Premium
Company Announcements
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
6M ago
NTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >